Connor, Clark & Lunn Investment Management (CC&L)’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$365K Sell
2025
Q1
$574K Buy
2024
Q4
$1.05M Buy
2024
Q3
$843K Buy
2024
Q2
$414K Buy
2024
Q1
$307K Buy